Reagents & consumables

Active Purchase Order Awarded Last action

Contract number
W81K0223P0125
Awardee
Awarding agency
Obligated
$505,847

Award facts

Opportunity
Contract value 75% obligated
$674,367.19 Current and potential, with all options
Completion date 76% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
LEWIS MCCHORD, WA 98431, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00010 $0
Other Administrative Action P00009 · In vitro diagnostic reagents and test kits $0
Other Administrative Action P00008 $0
Funding Only Action P00007 · Statement of work $168,833
Novation Agreement P00006 $0
Exercise an Option P00005 · Statement of work in vitro diagnostic reagents and test kitsmadigan army medical CENTER1. Scope of work: this is a supply only contract. The contractor will… $0
Supplemental Agreement for work within scope P00004 · MTS a/b/d mono & reverse GRP card - DE-obligate FY 24 funding (clins 0001, 0007, 0015) and update product code clin(s) 1006, 2006, 3006. -$653
Funding Only Action P00003 · MTS a/b/d mono & reverse GRP card - obligate funding $168,833
Exercise an Option P00002 · Modification - exercise option (1) MTS a/b/d mono & reverse GRP card $0
Funding Only Action P00001 · Modification - funding base year - MTS a/b/d mono & reverse GRP card $168,833
Original award $0
Show all 11

About this award

Written by GovTribe AI ·

The Defense Health Agency awarded a purchase order to Quidelortho Sales Company, LLC, a HUBZone-certified joint venture, for $674,367.19 in in vitro diagnostic reagents and consumables, effective October 1, 2023 through September 30, 2027. Work is performed at Lewis McChord, Washington. The order supplies reagents and consumables for an Ortho Vision Analyzer at Madigan Army Medical Center, including over one hundred blood bank testing reagents and consumables to be invoiced monthly through the Wide Area Workflow system. The procurement originated from a pre-solicitation posted July 24, 2023, evaluated under NAICS 325413 (in-vitro diagnostic substance manufacturing) and PSC 6550.

Quick answers

Who was awarded contract W81K0223P0125?

W81K0223P0125 was awarded to Quidelortho Sales Company, LLC by Defense Health Agency (Department of Defense) on October 1, 2023.

How much is contract W81K0223P0125 worth?

The government has obligated $505,847 on W81K0223P0125. Its current value, with exercised options, is $674,367.

Was contract W81K0223P0125 competed?

The extent of competition for W81K0223P0125 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login